1) 大野正文,犬走英介,秦 利之 : 子宮がんとPET検査.産婦人科治療89 : 292─295, 2004
2) 正津 晃,井出 満,安田聖栄,他 : PETを中心とした成人病検診.日本医事新報社,p154, 2002
3) Reinhardt MJ, Ehritt Braun C, Vogelgesang D, et al : Metastatic lymph node in patients with cervical cancer : detection with MR imaging and FDG PET. Radiology 218 : 776, 2001
4) Nakamoto Y, Eisbruch A, Achtyes ED, et al : Prognostic value of positron emission tomography using F─18─fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 84 : 289, 2002
5) Ma SY, See LC, Lai CH, et al : Delayed(18)F─FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 44 : 1775, 2003
6) Ioannidis JPA, Lau J : 18F─FDG PET for the diagnosis and grading of soft─tissue sarcoma : A meta─analysis. J Nucl Med 44 : 717, 2003
7) Garacia─Velloso M, Lopez G, Galen M, et al : Clinical value of positron emission tomography with F─18─FDG in the follow up patients with cancer of the ovary. An Sist Sanit Navar 25 : 21, 2002
8) Zimmy M, Siggelkow W, Schroder W, et al : 2─[Fluorine─18]─fluoro─2─deoxy─D─glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 83 : 310, 2001
9) Rose PG, Faulhaber P, Miraldi F : Positron emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma : correlation with second─look laparotomy. Gynecol Oncol 82 : 17, 2001
10) Miller TR, Pinkus E, Dehdashti F, et al : Improved prognostic value of 18F─FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med 44 : 192, 2003
11) Que TH, Boonstra H, Zee AG, et al : Assessment of the pelvis with FDG─PET : is dilution the solution?.J Nucl Med 41 : 285, 2000